Current Thoracic Surgery 2016 , Vol 1 , Issue 1
Bilobectomy in non-small cell lung carcinoma: an analysis of indications and outcome with a review of the literature
Özgür Samancılar1,Tevfik İlker Akçam2,Şeyda Örs Kaya1,Onur Akçay3,Kenan Can Ceylan1,Serpil Sevinç1,Şaban Ünsal1
1Department of Thoracic Surgery, Dr. Suat Seren Chest Disease and Thoracic Surgery Training and Research Hospital, İzmir, Turkey
2Department of Thoracic Surgery, School of Medicine, Ege University, İzmir, Turkey
3Department of Thoracic Surgery, Karşıyaka State Hospital, İzmir, Turkey
DOI : 10.26663/cts.2016.0002 Viewed : 987 - Downloaded : 803 Background: The gold standard of treatment for non-small cell lung cancer (NSCLC) is anatomic pulmonary resection. Wider resection methods may be preferred due to the size or anatomic location of the tumor. One method of choice is bilobectomy due of the anatomy of the right lung.

Materials and Methods: This study retrospectively analyzed 93 patients who were diagnosed with NSCLC and had bilobectomy, complete resection, and mediastinal lymph node dissection at our center between January 2005 and April 2013.

Results: Forty-seven patients underwent superior bilobectomy (sBL), and 46 patients underwent inferior bilobectomy (iBL). Bilobectomy was performed due to fissure invasion in 51 (58.1%) patients, internal or external bronchial tumor invasion in 31 (33.3%) patients, external bronchial lymph node invasion in six (6.4%) patients, and vascular invasion in two (2.2%) patients. The bronchial invasion-based indications were significantly higher in the iBL group compared to the fissure invasion-based indications in the sBL group (P < 0.001).

Conclusions: Bilobectomy leads to a substantial amount of parenchymal loss in the right lung, but it is a procedure that should be performed under the necessary conditions. It is obvious that performing bilobectomy under proper indications would result in good outcomes for lung cancer patients. Keywords : Bilobectomy; lung cancer; treatment